Clinical trials
Completed Cardiovascular Diseases trials in the United Kingdom
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
205 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2003 | 3 |
| 2004 | 1 |
| 2005 | 1 |
| 2006 | 3 |
| 2007 | 2 |
| 2008 | 4 |
| 2009 | 15 |
| 2010 | 12 |
| 2011 | 8 |
| 2012 | 17 |
| 2013 | 4 |
| 2014 | 16 |
| 2015 | 8 |
| 2016 | 17 |
| 2017 | 18 |
| 2018 | 18 |
| 2019 | 10 |
| 2020 | 15 |
| 2021 | 7 |
| 2022 | 11 |
| 2023 | 5 |
| 2024 | 6 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 205 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University of Reading | 12 |
| AstraZeneca | 10 |
| Queen Mary University of London | 9 |
| University of Leicester | 7 |
| Imperial College London | 6 |
| NHS Greater Glasgow and Clyde | 6 |
| GlaxoSmithKline | 5 |
| Loughborough University | 5 |
| Quadram Institute Bioscience | 5 |
| University of Aberdeen | 5 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cardiovascular Diseases | 205 |
| Heart Diseases | 18 |
| Diabetes Mellitus, Type 2 | 15 |
| Diabetes Mellitus | 14 |
| Atherosclerosis | 13 |
| Inflammation | 13 |
| Coronary Artery Disease | 12 |
| Hypertension | 12 |
| Heart Failure | 11 |
| Coronary Disease | 10 |
Trials
Showing 1 to 25 of 205. Each trial links to its page on Pharma Observatory.
105 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.